Magic mushrooms have a long and rich history. Now scientists say they could play an important role in the future, with their active ingredient a promising treatment for depression.
The results from a small, phase two clinical trial have revealed that two doses of psilocybin appears to be as effective as the common antidepressant escitalopram in treating moderate to severe major depressive disorder, at least when combined with psychological therapy.
“I think it is fair to say that the results signal hope that we may be looking at a promising alternative treatment for depression,” said Robin Carhart-Harris, head of the center for psychedelic research at Imperial College London and a co-author of the study.
Photo: Reuters via Imperial College London
Carhart-Harris said psilocybin was thought to work in a fundamentally different way to escitalopram. While both act on the brain’s serotonin system, he said escitalopram seemed to work by helping people tolerate stress more easily.
“With a psychedelic it is more about a release of thought and feeling that, when guided with psychotherapy, produces positive outcomes,” he said, adding participants given psilocybin had often reported feeling they had got more fully to the root of why they were depressed.
However, Carhart-Harris cautioned against seeking out magic mushrooms — a class A drug in the UK — for DIY treatment.
Photo: AP
“That would be an error of judgment,” he said. “We strongly believe that the … psychotherapy component is as important as the drug action.”
The ￡1 million (US$1.37 million) trial builds on previous work by the team exploring how psilocybin affects the brain, and an earlier clinical trial in which the drug helped alleviate treatment-resistant depression in 12 patients.
Over the six-week trial, 30 out of 59 adults with moderate to severe major depressive disorder were randomly allocated to receive two 25mg doses of psilocybin three weeks apart — a dose that Carhart-Harris said was high enough to produce the kind of experiences often described as existential or even “mystical.” The day after the first dose of psilocybin, this group began a daily placebo.
The other 29 participants were given two very low, or “inactive,” doses of psilocybin three weeks apart. This was to ensure any differences in outcomes between the groups would not simply be down to the expectation of being given psilocybin. The day after the first dose of psilocybin, this group began a daily dose of escitalopram, the strength of which increased over time.
Each psilocybin session — which lasted six hours, including a three to four-hour “trip” for those on the high dose — was supervised by at least two mental health professionals, with the participants lying on their back, propped up by pillows and listening to emotionally evocative neoclassical music.
All participants received psychological therapy the day after a psilocybin session, as well as a phone or video call in the week after the first dose.
The results, published in the New England Journal of Medicine, reveal that after six weeks both groups showed, on average, a decrease in the severity of depressive symptoms, according to scores from a questionnaire completed by the participants. However, this reduction did not differ significantly between the two groups.
“Psilocybin therapy, as we predicted, works more quickly than escitalopram,” said Carhart-Harris.
He added that results from other scales were “tantalisingly suggestive of potential superiority of psilocybin therapy” not only for depression but other aspects of wellbeing. He warned the findings were not conclusive as the team did not take into account the number of comparisons being made.
However, the team noted that 57 percent of patients in the high-dose psilocybin group were judged to be in remission for their depression by the end of the six weeks, compared with 28 percent in the escitalopram group, while neither group had serious side-effects.
While the team said the results were promising, others said the study was not big enough to draw firm conclusions. Among other limitations, the majority of participants were white, middle-aged, highly educated and male, while participants may have been able to guess which treatment they received and there was no group given a placebo and therapy alone.
Anthony Cleare, professor of psychopharmacology at King’s College London, said the study provided “some of the most powerful evidence to date that psychedelics may have a role to play in the treatment of depression.”
However, he said far more data was needed before drugs such as psilocybin could be used outside of research, adding they would not replace existing treatments for depression.
Wooden houses wedged between concrete, crumbling brick facades with roofs gaping to the sky, and tiled art deco buildings down narrow alleyways: Taichung Central District’s (中區) aging architecture reveals both the allure and reality of the old downtown. From Indigenous settlement to capital under Qing Dynasty rule through to Japanese colonization, Taichung’s Central District holds a long and layered history. The bygone beauty of its streets once earned it the nickname “Little Kyoto.” Since the late eighties, however, the shifting of economic and government centers westward signaled a gradual decline in the area’s evolving fortunes. With the regeneration of the once
Even by the standards of Ukraine’s International Legion, which comprises volunteers from over 55 countries, Han has an unusual backstory. Born in Taichung, he grew up in Costa Rica — then one of Taiwan’s diplomatic allies — where a relative worked for the embassy. After attending an American international high school in San Jose, Costa Rica’s capital, Han — who prefers to use only his given name for OPSEC (operations security) reasons — moved to the US in his teens. He attended Penn State University before returning to Taiwan to work in the semiconductor industry in Kaohsiung, where he
On May 2, Chinese Nationalist Party (KMT) Chairman Eric Chu (朱立倫), at a meeting in support of Taipei city councilors at party headquarters, compared President William Lai (賴清德) to Hitler. Chu claimed that unlike any other democracy worldwide in history, no other leader was rooting out opposing parties like Lai and the Democratic Progressive Party (DPP). That his statements are wildly inaccurate was not the point. It was a rallying cry, not a history lesson. This was intentional to provoke the international diplomatic community into a response, which was promptly provided. Both the German and Israeli offices issued statements on Facebook
Perched on Thailand’s border with Myanmar, Arunothai is a dusty crossroads town, a nowheresville that could be the setting of some Southeast Asian spaghetti Western. Its main street is the final, dead-end section of the two-lane highway from Chiang Mai, Thailand’s second largest city 120kms south, and the heart of the kingdom’s mountainous north. At the town boundary, a Chinese-style arch capped with dragons also bears Thai script declaring fealty to Bangkok’s royal family: “Long live the King!” Further on, Chinese lanterns line the main street, and on the hillsides, courtyard homes sit among warrens of narrow, winding alleyways and
RSS